BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Lone Star Bio

  Mirna Therapeutics, Inc. to Present at Biotech Showcase™ 2012

  January 5, 2012

   · 

  1 min read
• BioMidwest

  BioVigilant Systems Inc. Changes Name to Azbil BioVigilant, Inc.

  January 5, 2012

   · 

  1 min read
• Policy

  LipoScience, Inc. Submits FDA 510(K) for Vantera® Clinical Analyzer

  January 5, 2012

   · 

  2 min read
• Business

  GlycoMimetics, Inc. Announces Two Key Leadership Promotions

  January 5, 2012

   · 

  1 min read
• Biotech Bay

  Thoratec Corporation Presentation at J.P. Morgan Healthcare Conference To Be Webcast

  January 5, 2012

   · 

  1 min read
• Policy

  AlloCure Inc.’s Investigational Treatment for Acute Kidney Injury Receives Fast Track Designation by FDA

  January 5, 2012

   · 

  1 min read
• Genetown

  Synageva BioPharma Announces Pricing of Public Offering of Common Stock

  January 5, 2012

   · 

  1 min read
• Genetown

  Syndexa Pharmaceuticals Corp. Expands Series B1 Financing Round With $8.5 Million Investment by MP Healthcare Venture Management

  January 5, 2012

   · 

  2 min read
• Business

  Ultragenyx In-Licenses Therapeutic Program for Rare Genetic Disease Mucopolysaccharidosis Type 7 from St. Louis University

  January 5, 2012

   · 

  3 min read
• Drug Development

  Baxter International, Inc. Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A

  January 5, 2012

   · 

  1 min read